HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating for Gossamer Bio (NASDAQ:GOSS) and maintained a $10 price target.
August 30, 2024 | 9:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a Buy rating for Gossamer Bio, maintaining a $10 price target, indicating confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst suggests a positive outlook for Gossamer Bio. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100